Clinical Trial Update: REST - Replacing Steroids in the Transplant Ineligble [Phase 2]

View source ↗

Summary

A Phase 2 trial update on REST (Replacing Steroids in the Transplant Ineligible) for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Oslo University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED